|
2025
|
Invention
|
Combination treatments for depression utilizing an nmdar antagonist.
Provided herein are combina... |
|
|
Invention
|
Composition and method for treatment of depression and psychosis in humans.
This application rel... |
|
2024
|
Invention
|
Formulations for treatment of post-traumatic stress disorder.
Provided herein are compositions f... |
|
2022
|
Invention
|
Combined therapy for nmdar antagonist-responsive neuropsychiatric disorders.
Described herein ar... |
|
2021
|
Invention
|
Formulations for treatment of post-traumatic stress disorder. Provided herein are compositions fo... |
|
2020
|
Invention
|
Composition and method for treatment of depression and psychosis in humans. This application rela... |
|
2018
|
Invention
|
Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists. This a... |
|
|
Invention
|
Composition and method for treatment or depression and psychosis in humans. This application rela... |
|
|
Invention
|
Combined therapy for nmdar antagonist-responsive neuropsychiatric disorders. Described herein are... |
|
2017
|
Invention
|
Composition and method for treatment of depression and psychosis in humans. Compositions and meth... |
